Recent advances in the management of renal cell carcinoma

Therapeutic options for patients with metastatic renal cell carcinoma have significantly improved over the past few years with the recent approval of two new agents resulting in prolonged progression-free and overall survival.

Detalles Bibliográficos
Autores principales: Molina, Ana M., Nanus, David M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000Research 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4806703/
https://www.ncbi.nlm.nih.gov/pubmed/27019698
http://dx.doi.org/10.12688/f1000research.7935.1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4806703/
https://www.ncbi.nlm.nih.gov/pubmed/27019698
http://dx.doi.org/10.12688/f1000research.7935.1

Ejemplares similares